Catasys Reports Revenue Increase of 200% to $3.8 million for the Fourth Quarter of 2016

LOS ANGELES, March 1, 2017    Generated Positive EBITDA in Fourth Quarter 2016  Full Year 2016 Revenue Increased 162% to $7.1 million  $1.5 million in Deferred Revenue as of Dec. 31, 2016 LOS ANGELES, March 1, 2017, CATS, /PRNewswire/ Catasys, Inc. (CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, today reported its financial results for the three-month period and full year ended December 31, 2016. Revenue increased by 200% to $3.8 million for the fourth
http://bit.ly/2mdIP13